North America Molecular Quality Controls Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Molecular Quality Controls Market
Brand: Bussiness Insights

North America Molecular Quality Controls Market: by Type (Independent Controls, Instrument-Specific Controls, Third-Party Controls), Application (Infectious Disease, Oncology, Genetics, Blood Screening, Microbiology, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Wholesalers, Others), Technology (PCR, NGS, Microarray, Isothermal Amplification, Mass Spectrometry, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20365 | Author: Ankit

RD TOC Segmentation Research Methodology Request For Free Sample

North America Molecular Quality Controls Market Outlook & Forecast (2025-2035)

The North America Molecular Quality Controls Market is set for robust growth through 2035, driven by technological advancements and expanding applications in clinical diagnostics. Innovations such as enhanced PCR and Next-Generation Sequencing (NGS) platforms are reshaping quality control standards, improving assay accuracy, and enabling early disease detection. The market's expansion is supported by the increasing need for compliance in regulated laboratory environments and the growing focus on personalized healthcare. Increasing investments, a surge in infectious disease testing, and genomics-based research across the US, Canada, and Mexico are setting the stage for sustained market development. Distribution diversification—through direct sales, e-commerce, and partnerships—bolsters market reach.

Latest Market Dynamics

Key Drivers

Rising incidence of infectious diseases and oncology, fueling demand for reliable molecular quality controls in clinical laboratories. For instance,

Shift towards third-party and customizable quality controls, as labs seek flexibility and interoperability. Bio-Rad Laboratories expanded its third-party QC portfolio in Q1 2025 to meet diverse laboratory requirements.
Increased adoption of digital health platforms in distribution, with companies like Abbott Laboratories integrating their QC products with cloud-based lab informatics for remote monitoring and compliance.

Expanding applications in genetic and blood screening, where demand for high-precision QCs is rising. Danaher Corporation in 2025 unveiled genetics-focused QC kits targeting North American reference labs.
Emergence of AI-driven analytics in QC data interpretation. LGC Limited partnered in 2025 with software firms to develop predictive QC monitoring, creating openings for value-added digital solutions.

Cost barriers and reimbursement limitations, particularly for small and medium-sized clinical labs, restrict market access. Microbiologics is addressing this with cost-effective QC solutions aimed at community labs launched in early 2025.
Complex regulatory landscape imposing frequent changes. SeraCare Life Sciences published regulatory support guides in March 2025 to help labs maintain compliance amid evolving North American regulations.

In 2025, the North America Molecular Quality Controls Market is led by Independent Controls, which account for the majority share owing to their versatility across diverse platforms. Instrument-Specific Controls and Third-Party Controls also hold significant portions as laboratories seek specialized and interoperable solutions. Custom and internal/external controls present growing opportunities as laboratories increasingly look to tailor quality systems to their unique workflows and regulatory demands.

In 2025, Infectious Disease remains the dominant application segment, owing to sustained post-pandemic surveillance and routine pathogen screening. Oncology follows closely due to rising cancer diagnostic rates and genetic testing for personalized medicine. Blood Screening holds a substantial share, reflecting rising demand for safe transfusions and early disease detection. The increasing importance of genetics, microbiology, and other applications underlines the broadening scope of molecular quality controls in North American healthcare.

Market revenue for North America Molecular Quality Controls is projected to expand from $520 Million in 2020 to $980 Million by 2025, reaching beyond $2600 Million by 2035. Growth is propelled by increasing clinical application, regulatory enforcement, and digital transformation in diagnostics. The revenue trajectory reflects accelerated adoption post-pandemic, with robust investments in automation and precision diagnostics expected to sustain high single-digit CAGR throughout the forecast period.

In 2025, the United States dominates the North American molecular quality controls market, holding approximately 67% market share, attributed to advanced healthcare infrastructure, high research investments, and robust regulatory compliance. Canada follows with 21%, benefiting from continuous upgrades in diagnostic labs and increased genetic testing. Mexico is rapidly emerging with a 12% share as medical laboratory networks modernize and disease management programs expand.

The competitive landscape in 2025 is led by Bio-Rad Laboratories with 23% of share, driven by a comprehensive QC product range and innovation leadership. Thermo Fisher Scientific and Roche Diagnostics hold 16% and 12% respectively, leveraging global networks and robust R&D investment. Other notable players include Danaher Corporation and Abbott Laboratories, while niche providers capture increasing specialty and regional market segments.

Clinical laboratories represent the largest buyer segment for molecular quality controls in North America, accounting for 49% of the market due to extensive routine and specialized diagnostic testing. Reference laboratories follow at 31%, leveraging high-throughput platforms for advanced disease detection and genetics. Hospital-based labs comprise 13%, while others include blood banks, biopharma, and CROs collectively forming the remainder.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	980
Regions	United States, Canada, Mexico
Segments	Type: Independent Controls, Instrument-Specific Controls, Third-Party Controls, Internal Controls, External Controls, Custom Controls; Application: Infectious Disease, Oncology, Genetics, Blood Screening, Microbiology, Others
Players	Bio-Rad Laboratories, Thermo Fisher Scientific, Roche Diagnostics, Danaher Corporation, LGC Limited, Microbiologics, SeraCare Life Sciences, Abbott Laboratories, ZeptoMetrix Corporation, QuidelOrtho Corporation, Randox Laboratories, Streck Inc., Bio-Techne Corporation, Maine Molecular Quality Controls, Exact Diagnostics

June 2024: Bio-Rad Laboratories introduced a new multiplex infectious disease QC solution optimized for high-throughput labs.
July 2024: Abbott Laboratories expanded digital QC integration with leading laboratory information management systems (LIMS) in US facilities.
August 2024: SeraCare Life Sciences launched regulatory guideline support kits for molecular QC adaptation to U.S. and Canadian standards.
September 2024: Roche Diagnostics unveiled an AI-powered QC automation platform, enhancing result reliability for oncology diagnostics.
October 2024: Danaher Corporation announced a genetics-targeted QC product line with enhanced compatibility for next-generation sequencers.

About the Author

Ankit

Senior Research Consultant

Ankit is a Senior Research Consultant specializing in market research, industry analysis, and business consulting across Healthcare. Ankit brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Ankit has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Molecular Quality Controls Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Molecular Quality Controls Market Outlook & Forecast (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Molecular Quality Controls Market Share by Type, 2025

North America Molecular Quality Controls Market Share by Application, 2025

North America Molecular Quality Controls Market Revenue (USD Million), 2020-2035

North America Molecular Quality Controls Market YOY (%), 2020-2035

North America Molecular Quality Controls Market Share by Region, 2025

North America Molecular Quality Controls Market Players Share, 2025

North America Molecular Quality Controls Market Share by Buyers, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports